Proteins containing PDZ domains play a general role in recruiting receptors and enzymes to specific synaptic sites. In C. elegans, a complex of three PDZ 1 proteins, LIN-2/-7/-10 mediates basolateral targeting of a receptor tyrosine kinase. 
INTRODUCTION
Neuronal development and function require polarized sorting of protein complexes to appropriate cellular domains within neurons. At synapses neurotransmitter receptors must align at the postsynaptic density (PSD) opposed to the presynaptic active zone. Although mechanisms for protein trafficking to synapses and other specializations in neurons remain poorly understood, recent work identifies a general role for proteins containing PDZ domains in synaptic targeting (1) (2) (3) .
PDZ motifs are modular 80 amino acid domains that mediate protein-protein interactions in a variety of cellular contexts. PDZ domains contain a conserved peptidebinding grove that associates with the extreme C-terminus of interacting protein ligands or with appropriate internal binding motifs (4, 5) . In addition to binding to certain receptors, PDZ containing complexes also recruit cytosolic signaling enzymes to appropriate plasma membrane domains (1) (2) (3) .
Genetic studies of invertebrates have shown that PDZ proteins often play essential roles in regulating cellular signaling pathways. Mutations of Drosophila discs large, a MAGUK related to PSD-95 cause overgrowth of imaginal discs and abnormalities of larval neuromuscular junction (6, 7) . In C. elegans, mutations of a set of three PDZ proteins, LIN-2, LIN-7, and LIN-10, disrupt differentiation of vulval precursor cells and yield a vulvaless phenotype (8) . A series of elegant biochemical and cell biological studies showed that LIN-2/7/10 form a stable complex in which LIN-2 directly binds to both LIN-7 and LIN-10 (8). Interestingly, these interactions do not involve the PDZ domains, which remain free to interact with other cellular proteins (9) . Specifically, the PDZ domain from LIN-7 binds the extreme C-terminus of LET-23 and mediates basolateral localization of this receptor.
The LIN-2/7/10 complex also occurs prominently in neurons. Disruption of lin-10 in C. elegans prevents proper postsynaptic sorting of the GLR-1 glutamate receptor (10) . In mammals, close homologs of LIN-2 (CASK), LIN-7 (MALS/Veli) and (Mint/X11) have all been identified and the LIN-2/7/10 complex occurs at highest levels in brain (9, 11, 12) . However, specific roles for the LIN-2/7/10 complex in brain remain uncertain. Some studies have suggested that this complex regulates presynaptic functions (9) whereas others have implicated postsynaptic roles (12) . Immunohistochemical studies show CASK is ubiquitous in brain and occurs at both pre-and postsynaptic sites (13, 14) . Mint has also been found in numerous neuronal populations in brain . The cellular localizations for MALS in brain remain unknown.
Here, we have developed antisera to the family of mammalian LIN seven (MALS/Veli) homologs. Immunohistochemical staining of brain shows a heterogeneous distribution for these proteins, such that each MALS shows discrete localization in specific neuronal populations and both dendritic and axonal sites are labeled. In general, cells are endowed with only one MALS protein; however, certain neurons express multiple MALS isoforms. Targeted disruption of MALS-1 and MALS-2 does not yield a detectable phenotype and synaptic function in hippocampus is apparently intact in the double knockouts. Interestingly, disruption of MALS-1/2 proteins results in selective upregulation of MALS-3. This differential localization and dynamic induction of MALS suggest that protein expression is an important point for regulation of this family of synaptic PDZ proteins.
EXPERIMENTAL PROCEDURES

Isolation of MALS-1 genomic DNA and construction of targeting vector.
To isolate mouse MALS-1 cDNA, the N-terminal 250 bp was PCR-amplified from first-strand mouse brain cDNA using primers based on the human MALS-1 sequence (12) . This mouse cDNA probe was used to isolate a bacterial artificial chromosome (BAC) clone from a 129Sv/J mouse genomic library (Genome Systems, St. Louis, MO). The position of a 119-bp protein coding exon (2nd exon; +83-201 bp from the initiation ATG codon) was determined by DNA sequencing. The targeting vector was constructed using the pPNT replacement vector. A 1-kb intronic region downstream from the targeted exon was PCR-amplified, digested with XhoI and NotI, and subcloned into the XhoI/NotI sites of pPNT. Similarly, a 6-kb genomic region upstream to the exon was PCR-amplified, digested with KpnI and NheI, and inserted into the KpnI/XbaI sites of the pPNT vector.
PCR primers used were: TTACTCGAGGATCCGGACGCCGAGAATGTAACAACTG + TAAGCGGCCGCCCAGCCTTTGATTAACTTACAGGTTG for the 1 kb region, and GAGTTAGGTACCCAACTCTTCCTTATCAGCTCTTTTCC + CACTTAGCTAGCGAACACAACCTCCCTAATTAATCTC for the 6 kb region. In the targeting vector (MALS-1 LH6SH1), the 2nd exon and 2.2 kb of flanking sequence were replaced with a neo-cassette. The HSV-tk gene was included to allow for negative selection of non-recombinants. Primary antibodies were diluted (0.5 µg/ml) in blocking solution containing 2% BSA, 0.1% Tween-20 in TBS and incubated with membranes overnight at 4 o C.
Generation of MALS
Immunolabeled bands were visualized using enhanced chemilluminescence. Data was filtered at 5 KHz and stored directly to disk using the Igor Pro software (Wavemetrics) and analyzed online. Responses were filtered at 5 kHz and digitized at 10 kHz. All measurements are given as mean ± standard error of the mean. Statistical significance was tested using Students t-test
RESULTS
Characterization of Antisera to MALS-1, 2, 3-To map the localization of MALS
proteins throughout the brain we developed specific antisera to each protein. As MALS-1, 2, 3 share >80% sequence identity, antigens for peptide antibodies were carefully designed to avoid cross-reaction. We first characterized the antisera by western blotting.
Homogenates from mouse brain or COS cells transfected with each of the MALS cDNAs were separated by SDS/PAGE, and following transfer, blots were probed with affinitypurified antibodies to each of the MALS proteins. Previous studies have shown that MALS-1 migrates at 29 kD and that MALS-2, 3 migrate at 26 kD (9, 12) . As shown in (Fig. 2) . MALS-1 protein occurs at highest levels in cerebellum and olfactory bulb and is also expressed in superior colliculus, cerebral cortex, hippocampus, striatum, substantia nigra and hypothalamus ( Fig. 2A) . By contrast, MALS-2 expression is weak in cerebellum and olfactory bulb, but is enriched in cerebral cortex, thalamus, hippocampus and susbtantia nigra ( Fig. 2A ). MALS-3 shows the most restricted expression in brain and occurs at highest levels in the cerebellum, olfactory bulb, and superior colliculus and dentate gyrus of hippocampus ( Fig. 2A) .
In situ hybridization for MALS-1, 2, 3 generally correlates to that seen by immunohistochemistry (Fig. 2B) . That is, highest levels for MALS-1 mRNA are found in cerebellar granule cells, cerebral cortex and dentate gyrus of the hippocampus.
MALS-1 mRNA occurs at highest levels in neurons of the inferior olive, which also stain positive for MALS-1 protein (data not shown). MALS-2 hybridization is low in cerebellum but is readily detected in cerebral cortex, hippocampus, pontine nucleus and inferior olive. MAL-3 mRNA is detected only very weakly throughout the brain but found above background levels in hippocampal dentate gyrus. In a few brain regions there are discrepancies between localization signals detected by immunohistochemistry and in situ hybridization. For example, MALS-2 is enriched in the thalamus by immunohistochemistry but not by in situ hybridization. Also MALS-2 is positive in the pontine nucleus by in situ hybridization but faint by immunohistochemistry. These differences are likely attributable to subcellular sorting of MALS proteins to axons or dendrites.
Higher power micrographs were used to reveal the cellular distribution of the MALS proteins in specific neuronal populations. Throughout the brain, MALS are found predominantly in neurons and occur differentially in neuronal cell bodies and neuropil.
In substantia nigra pars compacta (Fig. 3A ) and ventral thalamus (Fig. 3E) , MALS-1 staining is prominent in neuronal cell bodies. By contrast, MALS-1 is distributed diffusely in the neuropil of cerebral cortex, superior colliculus and corpus striatum ( Fig.   3B-D) . MALS-2 expression is prominent in cell bodies of substantia nigra pars compacta but is also enriched in the neuropil of the substantia nigra pars reticulata (Fig.   3F ). In cerebral cortex, MALS-2 intensely labels interneurons (Fig. 3G, H) , which are devoid of MALS-1 or MALS-3. MALS-2 also strongly stains neurons of the pontine tegmental nucleus (Fig. 3I ). MALS-3 staining occurs diffusely in neuropil of specific brain regions including the superior colliculus (Fig. 3J) , the reticular thalamic nucleus and the olfactory bulb (Fig. 2K, L) . in the dendritic fields of hippocampal dentate granule cells. By contrast, MALS-2 is absent from the dentate gyrus of hippocampus. Instead, MALS-2 is abundant in the neuropil of the CA1 region (Fig. 8C) . Also, as found in cerebral cortex, MALS-2 is strikingly concentrated in cell bodies and processes of interneurons. MALS-3 expression in hippocampus is weak, but generally resembles that of MALS-1 in the molecular layer of the dentate gyrus (Fig. 8E) .
In cerebellum, MALS-1 is enriched in the cerebellar granule cell layer and is clearly concentrated in the glomeruli. MALS-1 also occurs diffusely in the molecular layer of cerebellum (Fig. 9A ). MALS-2 expression in cerebellum resembles that of MALS-1 but is much weaker. Peroxidase staining for MALS-2 shown in figure 9C was intentionally prolonged to bring out the very light labeling. MALS-3 in cerebellum is restricted to the molecular layer (Fig. 9E) . were probed with a pan-MALS antibody that reacts with all three isoforms. As shown in figure 4D , MALS-1 staining is selectively lost in the MALS-1 knockout. Similarly, immunoblotting extracts from wild-type, MALS-2 +/-, and MALS-2 -/-with isoform specific antibodies shows the expected loss of MALS-2 in the knockouts (Fig. 5D ).
Targeted disruption of MALS-1/2-Because
To generate double knockouts (DKO) the MALS-1 and MALS-2 mutants were interbred (Fig. 6 ). F1 progeny, which are heterozygous for each gene, were intercrossed and 99 pups were analyzed. These F2 pups were born in the predicted Mendelian ratios and included 6 DKOs (Fig. 6D ). As expected, western blotting of total brain homogenates showed that MALS-1 and MALS-2 are absent from the DKOs. MALS-1/2 DKOs are viable, fertile and cannot be distinguished from their littermates. (Fig. 8) . As expected, MALS-1 and MALS-2 staining are abolished in the DKOs (Fig. 8B, D) . Strikingly, MALS-3 expression in the DKOs is upregulated in the dentate gyrus and the CA-1 layer of hippocampus ( Fig.   8F ), which normally express MALS-1 and MALS-2, respectively. However, no upregulation of MALS-3 is seen in hippocampal interneurons, which robustly express MALS-2 in wild type mice. We also assessed possible compensation in cerebellum (Fig.   9 ). As expected, MALS-1 and MALS-2 staining were lost from cerebellar glomeruli of the DKO mice (Fig. 9B, D) . This loss of MALS-1, 2 was compensated by a dramatic upregulation of MALS-3 in cerebellar glomeruli (Fig. 9 F) .
Normal Synaptic Transmission and plasticity in the MALS-1/2 DKO-We
DISCUSSION
A primary finding of this study is that MALS proteins occur discretely in specific neuronal populations throughout the brain. This neuronal distribution in mammalian brain contrasts with the localization of LIN-7 to epithelial cells in C. elegans (17) . In of synaptic function (9, 11, 12) .
We were unable to assign MALS isoforms to specific neurotransmitter systems. Biochemical studies have demonstrated that MALS occur in a tight complex with CASK and Mint-1, which are the mammalian homologs of LIN-2 and LIN-10, respectively (9, 11, 18) . An N-terminal domain of MALS binds to CASK, which is a membrane associated guanylate kinase that occurs at cell junctions in association with neurexins and syndecan heparin sulfate proteoglycans (13, 14) . CASK is also suggested to translocate to the nucleus and regulate transcription by T-brain-1 (19 
